OPEN IN READ APP
JOURNAL ARTICLE

Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Adverse Cardiovascular Events: A Population-based Cohort Study

Kristian B Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H Yu, Samy Suissa
British Journal of Clinical Pharmacology 2019 July 5
31276600

AIMS: Sulfonylureas are recommended as second-line treatment in the management of type 2 diabetes. However, they are still commonly used also as first-line treatment instead of metformin. Given the controversial cardiovascular safety of sulfonylureas, we aimed to determine if their use as first-line treatment is associated with adverse cardiovascular events among patients with newly-treated type 2 diabetes compared with metformin.

METHODS: We conducted a population-based cohort study of patients with newly-treated type 2 diabetes using the United Kingdom's Clinical Practice Research Datalink. Initiators of metformin and sulfonylurea monotherapy were matched on high-dimensional propensity score, and Cox proportional hazards models were used to compare the rate of cardiovascular events (myocardial infarction [MI], ischemic stroke, cardiovascular death, and all-cause mortality) with sulfonylureas versus metformin.

RESULTS: Our cohort included 94,750 patients initiating treatment for type 2 diabetes, 17,612 on a sulfonylurea and 77,138 on metformin. After matching, sulfonylurea monotherapy, compared with metformin monotherapy, was not associated with an increased risk of MI (HR: 1.04, 95% CI: 0.85 to 1.25) but was associated with increased risks of ischemic stroke (HR: 1.25, 95% CI: 1.002 to 1.56), cardiovascular death (HR: 1.25, 95% CI: 1.06 to 1.47), and all-cause mortality (HR: 1.60, 95% CI: 1.45 to 1.76). This represents an additional 2.0 ischemic strokes, 3.5 cardiovascular deaths, and 21.4 all-cause deaths per 1,000 patients per year with sulfonylureas.

CONCLUSIONS: Initiating treatment of type 2 diabetes with a sulfonylurea rather than metformin is associated with higher rates of ischemic stroke, cardiovascular death, and all-cause mortality.

Comments

You need to log in or sign up for an account to be able to comment.

No comments yet, be the first to post one!

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
31276600
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"